Positive test results | |||||
---|---|---|---|---|---|
Numbers analysed | Peak month | Amplitude (%) | Crude 95% CI* | Edwards’ & Roger’s P | |
All tests | |||||
0-14 | 1150 | March | 31.3 | 31.0-31.5 | <0.0001 |
15-24 | 6119 | February | 14.3 | 14.2-14.3 | <0.0001 |
25-44 | 1156 | March | 1.9 | 1.7-2.1 | 0.9 |
>45 | 222 | August | 18.3 | 17.0-19.6 | 0.3 |
All ages | 8647 | February | 13.8 | 13.8-14 | <0.0001 |
Female | |||||
0-14 | 691 | March | 32.4 | 32.0-32.8 | <0.0001 |
15-24 | 3300 | February | 16.2 | 16.1-16.3 | <0.0001 |
25-44 | 554 | February | 8.1 | 7.6-8.6 | 0.1 |
>45 | 101 | April | 29.1 | 26.3-31.8 | 0.3 |
All ages | 4646 | February | 16.6 | 16.6-17.0 | <0.0001 |
Male | |||||
0-14 | 459 | March | 29.9 | 29.3-30.5 | <0.0001 |
15-24 | 2819 | February | 11.9 | 11.8-12.0 | <0.0001 |
25-44 | 602 | July | 4.4 | 3.9-4.9 | 0.6 |
>45 | 121 | August | 20.3 | 18.1-22.7 | 0.2 |
All ages | 4001 | February | 10.5 | 10.5-10.6 | <0.0001 |
Total tests performed | |||||
Numbers analysed | Peak month | Amplitude (%) | Crude 95% CI* | Edwards’ & Roger’s P | |
All tests | |||||
0-14 | 9884 | February | 34.5 | 34.4-34.5 | <0.0001 |
15-24 | 30663 | February | 12.2 | 12.2-12.2 | <0.0001 |
25-44 | 17615 | April | 12.9 | 12.9-12.9 | <0.0001 |
>45 | 4066 | March | 13.0 | 12.9-13.1 | <0.0001 |
All ages | 62228 | February | 13.8 | 13.8-13.8 | <0.0001 |
Female | |||||
0-14 | 5565 | February | 32.1 | 32.0-32.2 | <0.0001 |
15-24 | 18873 | February | 13.1 | 13.1-13.1 | <0.0001 |
25-44 | 10936 | March | 16.6 | 16.5-16.6 | <0.0001 |
>45 | 2449 | March | 17.0 | 16.9-17.1 | <0.0001 |
All ages | 37823 | February | 14.4 | 14.4-14.4 | <0.0001 |
Male | |||||
0-14 | 4319 | February | 37.6 | 37.5-37.7 | <0.0001 |
15-24 | 11790 | February | 10.8 | 10.8-10.9 | <0.0001 |
25-44 | 6679 | April | 6.9 | 6.9-7.0 | 0.009 |
>45 | 1617 | March | 7.5 | 7.4-7.7 | 0.1 |
All ages | 24405 | February | 12.8 | 12.8-12.9 | <0.0001 |